DOI: http://dx.doi.org/10.18203/2349-2902.isj20181836

Current concepts in the management of enterocutaneous fistula

Amabra Dodiyi-Manuel, Promise N. Wichendu

Abstract


Enterocutaneous fistula is an abnormal connection between the intra-abdominal gastrointestinal tract and skin. It causes considerable morbidity and mortality. The goals of management are restoration of gastrointestinal continuity and allowance of enteral nutrition with minimal morbidity and mortality. A multidisciplinary approach is essential in the successful management and this has led to closure rates ranging from 5-20% following conservative management and 75-85% with operative treatment. This article seeks to review the current concepts in the management of enterocutaneous fistula. A systematic search of literature on enterocutaneous fistula was conducted. Relevant materials were selected and selected references from relevant books, journal articles and abstracts using Medline, Google scholar and Pubmed databases were critically reviewed. Enterocutaneous fistulas can be classified by the anatomy, aetiology or physiology. Anatomically, enterocutaneous fistula has been classified based on the organ of origin and this is useful in the consideration of management options: type l (abdominal oesophageal and gastroduodenal fistula), type ll (small bowel fistula), type lll (large bowel fistula) and type IV (enteroatmospheric, regardless of origin. The anatomy also depends on the presence or absence of associated abscess cavity and the length and characteristics of the fistula tract. Aetiologically, the majority of enterocutaneous fistulas are iatrogenic (75-85%) while between 15 and 25% occur spontaneously. The physiological classification is based on the volume of its output. High output fistulas drain more than 500mls in 24 hours, moderate output between 200 and 500mls in 24 hours and low output less than 200mls in 24 hours. Successful management requires a multidisciplinary approach and would consist of initial resuscitaion with fluids and electrolytes, control of sepsis, good and adequate nutrition, wound care and skin protection and definitive management. The treatment of enterocutaneous fistula is multidisciplinary and remains a challenge despite the recent improvement in supportive care. Once enterocutaneous fistula occurs, adequate stabilization of the patient and non-operative management should be commenced. If surgery is required, careful planning, meticulous dissection, restoration of bowel continuity and reconstruction of abdominal wall are critical.


Keywords


Closure, Enterocutaneous fistula, Management

Full Text:

PDF

References


Joyce MR, Dietz W. Management of complex gastrointestinal fistula. Curr Probl Surg 2009;46:384-430.

Draus JM Jr, Huss SA, Harty NJ, Cheadle WG, Larson GM. Enterocutaneous fistulas: are treatments improving? Surg. 2006;140:570-6.

Lynch AC, Delaney CP, Senagore AJ, Connor JT, Remi FH. Fazio VW. Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery. Ann Surg. 2004;240:825-31.

Brenner M, Clayton JL, Tillou A, Hiatt JR, Cryer HG. Risk factors for recurrence after repair of enterocutaneous fistula. Arch Surg 2009;144:500-5.

Connolly PT, Teubner A, Lees LP, Anderson ID, Scott NA, Carlson GL. Outcome of reconstructive surgery for intestinal fistula in the open abdomen. Am Surg. 2008;247:440-4.

Lloyd DA, Gabe SM, Windsor AC. Nutrition and management of enterocutaneous fistula. Br J Surg 2006;93:1045-55.

Martinez JL, Luque-de-Leon E, Mier J, Blanco-Benavides R, Robledo F. Systematic management of post-operative enterocutaneous fistula: factors related to outcomes. World J Surg. 2008;323:436-43.

Sitges-Sera A, Jaurrieta E, Sitges-Creus A. Management of post-operative enterocutaneous fistulas: the role of parenteral nutrition and surgery. Br J Surg. 1982;69:147-50.

Campos AC, Andrade DF, Campos GM, Matias JE, Coellio JC. A multivariate model to determine prognostic factors in gastrointestinal fistulas. J Am Coll Surg. 1999;188:483-90.

Mawdsley JE, Hollington P, Bassett P, Windsor AJ, Forbes A, Gabe SM. An analysis of predictive factors for healing and mortality in patients with enterocutaneous fistulas. Aliment Pharmacol Ther 2008;28:1111-21.

Schein M, Decker GA. Post operative external alimentary tract fistulas. Am J Surg. 1991;161:435-8.

Evenson AR, Fischer JE. Current management of enterocutaneous fistula. J Gastrointest Surg. 2006; 10:455-64.

Berry SM, Fischer JE. Classification and pathophysiology of enterocutaneous fistula. Surg Clin North Am. 1996;76:1009-18.

Levy E, Frileux P, Cugnenc PH, Honiger J, Oliver JM, Parc R. High-output external fistula of the small bowel: management of continuous enteral nutrition. Br J Surg. 1989;76:676-9.

Soeters PB, Ebeid AM, Fischer JE. Review of 404 patients with gastrointestinal fistulas. Impact of parenteral nutrition. Am Surg. 1979;190:189-202.

Harriman S, Rodych N, Hayes P, Moser MA. The C-reactive protein to albumin ratio predicts fistula closure. Am J Surg. 2011;202:175-8.

Hollington P, Mawdsley J, Lim W, Gabe SM, Forbes A, Windsor AJ. An 11 year experience of enterocutaneous fistula. Br J Surg. 2004;91:1646-51.

Irving M, White R, Tresadern J. Three years experience with an intestinal failure unit. Am R Coll Surg Engl. 1985;67:2-5.

Gribovskaja-Rupp I, Melton GB. Enterocutaneous fistula: proven strategies and updates. Clin Colon Rectal Surg. 2016;29:130-7.

Schecter WP, Hirshberg A, Chang DS, Harris HW, Napolitano LM, Wexner SD, et al. Enteric fistulas: principles of management. J Am Coll Surg. 2009; 209:484-91.

Kaushal M, Carlson GL. Management of enterocutaneous fistula. Clin Colon Rectal Surg 2004;17:79-88.

Haack CI, Gallloway JR, Srinivasan J. Enterocutaneous fistulas: A look at the causes and management. Current Surg Reports. 2014:2:71

Bleier JI, Hedrick T. Metabolic support of the enterocutaneous fistula patient. Clin Colon Rectal Surg 2010;23:142-8.

Dellinger RP, Levy MM, Rhodes A, Annane D, Geriach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for the management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580-637.

Dudrick SJ, Maharaj AR, Mckelvey aa. Artificial nutritional support in patients with gastrointestinal fistulas. World J Surg. 1999;23:570-6.

Majercik S, Kinikini M, White T. Enteroatmospheric fistula: from soup to nuts. Nutr Clin Pract. 2012;27:507-12.

Gianotti L, Alexander JW, Nelson JL, Fukushima R, Pyles T, Chalk CL. Role of early enteral feeding and acute starvation of post burn bacterial translocation and host defence: prospective randomized trials. Crit Care Med. 1994;22:265-72.

Datta V, Engledow A, Chan S, Forbes A, Cohen CR, Windsor A. The management of enterocutaneous fistula in a regional unit in the United Kingdom: a prospective study. Dis Colon Rectum. 2010;53:192-9.

Polk TM, Schwab CW. Metabolic and nutritional support of enterocutaneous fistula patient: a three phase approach. World J Surg. 2012;6:524-33.

Teubner A, Morrison K, Ravishankar HR, Anderson ID, Scott NA, Carlson GL. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. Br J Surg. 2004;91:625-31.

Nubiola P, Badia JM, Martinez-Rodenas F, Gil MJ, Segura M, Sancho J, et al. Treatment of 27 post operative enterocutaneous fistulas with long half-life somatostatin analogue SMS 201-995. Am Surg 1989;210:56-8.

Sancho JJ, diCostanzo J, Nubiola P, Larrad A, Bequiristain A, Roqueta F. Randomized double-blind placebo controlled trial of early octreotide in patients with enterocutaneous fistula. Br J Surg 1995;82:638-41.

Torres AJ, Landa JI, Moreno-Azcoita M, Arguello JM, Sillecchia G, Castro J, et al. SAomatostatin in the management of gastrointestinal fistulas. A multicenter trial. Arch Surg. 1992;127:97-9.

Cooper AM, Braatvedt GD, Qanear MI, Brown H, Thomas DM, Halliwell M. Fasting and post-prandial splanchnic blood flow is reduced by somatostatin analogue (octreotide) in man. Clin Sci. 1991;81:169-75.

Lattuada D, Casnici C, Crotta K, Mastrotto C, Franco P, Schmid HA. Inhibitory effect of pasireotide and octreotide on lymphocyte activation. J Neuroimmunol. 2007;182:153-9.

Brindle CT, Blankenship J. Management of complex wounds with small bowel fistulae: isolation techniques and exudate control to improve outcomes. J Wound Ostomy Continence Nurs 2009;36:396-403.

Alvarez AA, Maxwell GL, Rodriquez GC. Vacuum-assisted closure for cutaneous gastrointestinal fistula management. Gynecol Oncol. 2001;80:413-6.

Fischer J. A cautionary note: the use of vacuum-assisted closure systems in the treatment of gastrointestinal cutaneous fistula may be associated with higher mortality from subsequent fistula development. Am J Surg. 2008;196:1-2.

Rao M, Burke D, Finan PJ, Sagar PM. The use of vacuum-assisted closure of abdominal wounds: a word of caution. Colorectal Dis. 2007;9:266-8.

Rabago LR, Ventosa N, Castro JL, Marco J, Herrera N, Gea F. Endoscopic treatment of post operative fistulas resistant to conservative management using biological fibrin glue. Endoscopy. 2002;34:632-8.

Roben G. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg 2008;32:445-53.

Murphy M, Hotouraw A, Koers L, Bhan C, Glym M, Chan CL. Establishing a regional enterocutaneous fistula service: The Royal London Hospital Experience. Int J Surg. 2013;11:952-6.